Urine test may detect kidney cancer early
the ONA take:
According to a recent study published in JAMA Oncology, researchers at Washington University School of Medicine in St. Louis, Missouri, have developed a noninvasive urine test that screens for kidney cancer.
For the study of the screening method, researchers analyzed urine samples from 720 patients were about to undergo an abdominal CT scan for reasons other than suspicion of kidney cancer, 80 healthy people, and 19 patients previously diagnosed with cancer. The test measured levels of two proteins biomarkers in the urine.
Results showed that none of the 80 healthy people had increased levels of either biomarker and all of the 19 patients with kidney cancer had elevated levels of both. In addition, three of the 720 patients who underwent an abdominal CT scan had increased levels of both proteins; two were confirmed to have kidney cancer.
Ultimately, the protein biomarkers were over 95% accurate in identifying early-stage kidney cancer and the test did not result in any false-positive caused by non-cancerous kidney disease.
Researchers developed a noninvasive urine test that screens for kidney cancer.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genetic Similarity to BRCA1/BRCA2 Mutations May Impact Treatment Options
- Evidenced-Based Radiation Treatment Tied to Cost Savings in Early Stage Breast Cancer
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|